High dose liposomal aerosol formulations

The present invention provides a high dose pharmaceutical liposome aerosol composition comprising about 12-30 mg/ml of a pharmaceutical compound, and about 130-375 mg of a phospholipid/ml starting reservoir concentration. Specifically, the present invention is drawn to anti-inflammatory glucocortico...

Full description

Saved in:
Bibliographic Details
Main Authors J.C. WALDREP, M.B. BLACK, V. KNIGHT
Format Patent
LanguageEnglish
Published 20.11.2002
Edition7
Subjects
Online AccessGet full text

Cover

Loading…